Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Brodalumab in Psoriasis
NCT02052609Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Feb 2014
- Primary completion
- Jan 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of brodalumab in plaque psoriasis, psoriatic arthritis (PsA), generalized pustular psoriasis (GPP), erythrodermic psoriasis, sponsored by Kyowa Kirin. Started Feb 2014; status: completed.
02
Drugs
brodalumab
03
Conditions
plaque psoriasispsoriatic arthritis (PsA)generalized pustular psoriasis (GPP)erythrodermic psoriasis
Beyond the preview
Go deeper on NCT02052609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052609.